Discover
NPCE
NeuroPace, Inc.
14.28
2 x 10.16
2 x 17.12
bid
ask
+
0.13
0.92%
2 @ 04:00 PM
14.30 +0.02 (0.14%)
| Ytd | -7.51% | |
| 1y | 38.37% |
14.05
day range
14.56
9.22
52 week range
19.60
| Open | 14.17 | Prev Close | 14.15 | Low | 14.05 | High | 14.56 | Mkt Cap | 490.15M |
| Vol | 235.66K | Avg Vol | 185.91K | EPS | -0.47 | P/E | N/A | Forward P/E | -10.90 |
| Beta | 1.80 | Short Ratio | 2.85 | Inst. Own | 82.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 14.69 | 200-d Avg | 15.44 | 1yr Est | 16.17 |
NPCE News
benzinga.com
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy rati
benzinga.com
Keybanc Initiates Coverage On NeuroPace with Overweight Rating, Announces Price Target of $18
Keybanc analyst Brett Fishbin initiates coverage on NeuroPace (NASDAQ:NPCE) with a Overweight rat